ADVERSE REACTIONS
In controlled trials with clobetasol propionate formulations, the following adverse reactions have been reported: burning/stinging, pruritis, irritation, erythema, folliculitis, cracking and fissuring of the skin, numbness of the fingers, tenderness in the elbow, skin atrophy, and telangiectasia. The incidence of local adverse reactions reported in the trials with Temovate E® Emollient was less than 2% of patients treated with the exception of burning/stinging which occurred in 5% of treated patients.
Cushing's syndrome has been reported in infants and adults as a result of prolonged use of other topical clobetasol propionate formulations.
The following additional local adverse reactions are reported infrequently with topical corticosteroids, but may occur more frequently with super-high potency corticosteroids such as Temovate E® Emollient. These reactions are listed in an approximately decreasing order of occurrence: dryness, hypertrichosis, acneiform eruptions, hypopigmentation, perioral dermatitis, allergic contact dermatitis, secondary infection, striae, and miliaria.
|
REPORTS OF SIDE EFFECTS / ADVERSE REACTIONS RELATED TO TEMOVATE
Below is a sample of reports where side effects / adverse reactions may be related to Temovate. The information is not vetted and should not be cosidered as verified clinical evidence.
Possible Temovate side effects / adverse reactions in 70 year old female
Reported by a consumer/non-health professional from United States on 2007-05-30
Patient: 70 year old female weighing 68.0 kg (149.7 pounds)
Reactions: Drug Ineffective
Suspect drug(s):
Temovate
Other drugs received by patient: Glucophage; Doxephin; Vicotin; Erythrotec; Avapro; Vytorin
|
